5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one

C23H24F3N3O3 — CID 112807457

IUPAC5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one
SMILESCOc1ccc(C(NCC(=O)N2c3ccccc3NC(=O)CC2C(F)(F)F)C2CC2)cc1
InChIInChI=1S/C23H24F3N3O3/c1-32-16-10-8-15(9-11-16)22(14-6-7-14)27-13-21(31)29-18-5-3-2-4-17(18)28-20(30)12-19(29)23(24,25)26/h2-5,8-11,14,19,22,27H,6-7,12-13H2,1H3,(H,28,30)
InChIKeySPGJFBIRTFBMJZ-UHFFFAOYSA-N
MW447.46 g/mol
LogP4.04
Rot. Bonds6

About 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one

5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one (PubChem CID 112807457) has the molecular formula C23H24F3N3O3 and a molecular weight of 447.46 g/mol. Its IUPAC name is 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one.

Molecular Properties

Compound Name5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one
PubChem CID112807457
Molecular FormulaC23H24F3N3O3
Molecular Weight447.46 g/mol
Exact Mass447.18
IUPAC Name5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one
SMILESCOc1ccc(C(NCC(=O)N2c3ccccc3NC(=O)CC2C(F)(F)F)C2CC2)cc1
InChIInChI=1S/C23H24F3N3O3/c1-32-16-10-8-15(9-11-16)22(14-6-7-14)27-13-21(31)29-18-5-3-2-4-17(18)28-20(30)12-19(29)23(24,25)26/h2-5,8-11,14,19,22,27H,6-7,12-13H2,1H3,(H,28,30)
InChIKeySPGJFBIRTFBMJZ-UHFFFAOYSA-N
XLogP4.04
TPSA70.67 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500447.46
LogP ≤ 54.04
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one?
The IUPAC name of 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one (CID 112807457) is 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one.
What is the SMILES notation for 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one?
The canonical SMILES for 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one is COc1ccc(C(NCC(=O)N2c3ccccc3NC(=O)CC2C(F)(F)F)C2CC2)cc1.
What is the InChIKey of 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one?
The InChIKey is SPGJFBIRTFBMJZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24F3N3O3/c1-32-16-10-8-15(9-11-16)22(14-6-7-14)27-13-21(31)29-18-5-3-2-4-17(18)28-20(30)12-19(29)23(24,25)26/h2-5,8-11,14,19,22,27H,6-7,12-13H2,1H3,(H,28,30).
What are the key properties of 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one?
5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one has a molecular weight of 447.46 g/mol, XLogP of 4.04, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[2-[[cyclopropyl-(4-methoxyphenyl)methyl]amino]acetyl]-4-(trifluoromethyl)-3,4-dihydro-1H-1,5-benzodiazepin-2-one is sourced from PubChem (CID 112807457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).